Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-23
2005-08-23
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S200000, C544S111000, C546S269700, C514S231500, C514S342000
Reexamination Certificate
active
06933308
ABSTRACT:
Novel aminoalkylthiazole derivatives of Formula I are described which are openers of KCNQ potassium channels and are useful in the treatment of disorders responsive to the opening of the KCNQ potassium channels, including pain and migraine.
REFERENCES:
patent: 3689481 (1972-09-01), Scheuermann et al.
patent: 3794636 (1974-02-01), Girgis
patent: 3872124 (1975-03-01), LeMartret et al.
patent: 4923886 (1990-05-01), Shiokawa et al.
patent: 4980363 (1990-12-01), Shimotori et al.
patent: 5045554 (1991-09-01), Alt et al.
patent: 5057142 (1991-10-01), Baasner et al.
patent: 5244867 (1993-09-01), Ditrich et al.
patent: 5330995 (1994-07-01), Eicken et al.
patent: 5614520 (1997-03-01), Kondo et al.
patent: 5846990 (1998-12-01), Murugesan et al.
patent: 5859035 (1999-01-01), Anthony et al.
patent: 5888941 (1999-03-01), Bartroli et al.
patent: 6319940 (2001-11-01), Elbe et al.
patent: 57183768 (1982-11-01), None
patent: 01250379 (1989-10-01), None
patent: 02229190 (1990-09-01), None
patent: 04049290 (1992-02-01), None
patent: 04128275 (1992-04-01), None
patent: WO 95/19972 (1995-07-01), None
patent: WO 98/28282 (1998-07-01), None
patent: WO 99/59570 (1999-11-01), None
patent: WO 99/66925 (1999-12-01), None
patent: WO 00/06085 (2000-02-01), None
patent: WO 01/10798 (2001-02-01), None
patent: WO 01/40207 (2001-06-01), None
Robbins Pharmacology & Therapeutics 90: 1-19, 2001.
Jensen, CNS Drug Rev. 8(4): 353-60, 2002.
H.-S. Wang, et al, “KCNQ2 and KCNQ3 Potassium Channel Subunits: Molecular Correlates of the M-Channel,” SCIENCE, 282, pp. 1890-1893, 1998.
Boy Kenneth M.
Wu Yong-Jin
Balasubramanian Venkataraman
Bristol--Myers Squibb Company
Epperson James
LandOfFree
Aminoalkyl thiazole derivatives as KCNQ modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminoalkyl thiazole derivatives as KCNQ modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoalkyl thiazole derivatives as KCNQ modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3514538